Intralesional Talimogene Laherparepvec Immunotherapy for Melanoma: A Case Study. [PDF]
Ghebrehiwet M, Pavlis J, Gomez-Meade C.
europepmc +1 more source
The multilayered control of acetylation during adenovirus-based immunotherapy of cancer. [PDF]
Parthasarathy A+5 more
europepmc +1 more source
Oncolytic Virotherapy for Relapsed, IDH-Mutant, Grade 3 Astrocytoma: A New Promising Approach - A Case Report. [PDF]
Gesundheit B+8 more
europepmc +1 more source
Deubiquitination enzyme USP35 negatively regulates MAVS signaling to inhibit anti-tumor immunity. [PDF]
Zhang H+14 more
europepmc +1 more source
Oncolytic alphavirus-induced extracellular vesicles counteract the immunosuppressive effect of melanoma-derived extracellular vesicles. [PDF]
Bhatt DK+8 more
europepmc +1 more source
IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy. [PDF]
Huang Z+9 more
europepmc +1 more source
A NOVEL APPROACH OF VIROTHERAPY BASED HSF-1 shRNA IN CANCER ERADICATION
I Gede Putu Supadmanaba+1 more
openalex +1 more source
Innovative approaches to glioma treatment: Oncolytic foamy virus and CAR TÂ cell therapy. [PDF]
Amhis N.
europepmc +1 more source
What a model: A newly developed pancreatic murine cell line permissive to adenoviral replication. [PDF]
Fusciello M, Cerullo V.
europepmc +1 more source